Created
October 23, 2019 18:04
-
-
Save DannyHinshaw/224c810718ccee10567d0a7deee76d6a to your computer and use it in GitHub Desktop.
This file contains hidden or bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
| export const AFINITOR = [{ | |
| "TherapyContinuation_Plan": 173547, | |
| "ProductName": "Afinitor", | |
| "RxDed": 500, | |
| "Month11_Patient": 500, | |
| "Lives": 26088, | |
| "TherapyInitiation_Patient": 1000, | |
| "DrugTier": "4", | |
| "MedDed": 6300, | |
| "DedType": "Pharmacy", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 15777, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 15777, | |
| "Month8_Patient": 500, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 15777, | |
| "Month6_Patient": 500, | |
| "TherapyContinuation_Patient": 5500, | |
| "TherapyInitiation_Plan": 15277, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 500, | |
| "Month6_Plan": 15777, | |
| "Month2_Patient": 500, | |
| "Month3_Plan": 15777, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 500, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze 60 D EPO", | |
| "Month9_Plan": 15777, | |
| "TotalPlanCost": 188824, | |
| "Month9_Patient": 500, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 15777, | |
| "Month8_Plan": 15777, | |
| "Month7_Patient": 500, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6018, | |
| "Month4_Plan": 15777, | |
| "Month5_Patient": 500, | |
| "Month7_Plan": 15777, | |
| "MedOOP": 7550, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 500, | |
| "Month10_Plan": 15777, | |
| "Month10_Patient": 500, | |
| "DrugId": 2 | |
| }, { | |
| "TherapyContinuation_Plan": 178897, | |
| "ProductName": "Afinitor", | |
| "Month11_Patient": 0, | |
| "Lives": 11891, | |
| "TherapyInitiation_Patient": 6500, | |
| "DrugTier": "4", | |
| "MedDed": 6000, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 16277, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 16277, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 16277, | |
| "Month6_Patient": 0, | |
| "TherapyContinuation_Patient": 150, | |
| "TherapyInitiation_Plan": 9777, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 0, | |
| "Month6_Plan": 16277, | |
| "Month2_Patient": 150, | |
| "Month3_Plan": 16277, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze 60 D HDHP EPO", | |
| "Month9_Plan": 16277, | |
| "TotalPlanCost": 188674, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 16127, | |
| "Month8_Plan": 16277, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6019, | |
| "Month4_Plan": 16277, | |
| "Month5_Patient": 0, | |
| "Month7_Plan": 16277, | |
| "MedOOP": 6650, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 0, | |
| "Month10_Plan": 16277, | |
| "Month10_Patient": 0, | |
| "DrugId": 2 | |
| }, { | |
| "TherapyContinuation_Plan": 176897, | |
| "ProductName": "Afinitor", | |
| "Month11_Patient": 0, | |
| "Lives": 782, | |
| "TherapyInitiation_Patient": 5750, | |
| "DrugTier": "4", | |
| "MedDed": 5250, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 15777, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 16277, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 16277, | |
| "Month6_Patient": 150, | |
| "TherapyContinuation_Patient": 2150, | |
| "TherapyInitiation_Plan": 10527, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 500, | |
| "Month6_Plan": 16127, | |
| "Month2_Patient": 500, | |
| "Month3_Plan": 15777, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze Pathway EPO 5250", | |
| "Month9_Plan": 16277, | |
| "TotalPlanCost": 187424, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 15777, | |
| "Month8_Plan": 16277, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6020, | |
| "Month4_Plan": 15777, | |
| "Month5_Patient": 500, | |
| "Month7_Plan": 16277, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 500, | |
| "Month10_Plan": 16277, | |
| "Month10_Patient": 0, | |
| "DrugId": 2 | |
| }, { | |
| "TherapyContinuation_Plan": 177497, | |
| "ProductName": "Afinitor", | |
| "Month11_Patient": 0, | |
| "Lives": 1773, | |
| "TherapyInitiation_Patient": 6350, | |
| "DrugTier": "4", | |
| "MedDed": 5850, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 16227, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 16277, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 16277, | |
| "Month6_Patient": 0, | |
| "TherapyContinuation_Patient": 1550, | |
| "TherapyInitiation_Plan": 9927, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 500, | |
| "Month6_Plan": 16277, | |
| "Month2_Patient": 500, | |
| "Month3_Plan": 15777, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze Pathway EPO 5850", | |
| "Month9_Plan": 16277, | |
| "TotalPlanCost": 187424, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 15777, | |
| "Month8_Plan": 16277, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6021, | |
| "Month4_Plan": 15777, | |
| "Month5_Patient": 50, | |
| "Month7_Plan": 16277, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 500, | |
| "Month10_Plan": 16277, | |
| "Month10_Patient": 0, | |
| "DrugId": 2 | |
| }, { | |
| "TherapyContinuation_Plan": 178547, | |
| "ProductName": "Afinitor", | |
| "Month11_Patient": 0, | |
| "Lives": 1100, | |
| "TherapyInitiation_Patient": 7400, | |
| "DrugTier": "4", | |
| "MedDed": 6900, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 16277, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 16277, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 16277, | |
| "Month6_Patient": 0, | |
| "TherapyContinuation_Patient": 500, | |
| "TherapyInitiation_Plan": 8877, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 0, | |
| "Month6_Plan": 16277, | |
| "Month2_Patient": 500, | |
| "Month3_Plan": 16277, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze Pathway EPO 6900 Online Plus", | |
| "Month9_Plan": 16277, | |
| "TotalPlanCost": 187424, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 15777, | |
| "Month8_Plan": 16277, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6022, | |
| "Month4_Plan": 16277, | |
| "Month5_Patient": 0, | |
| "Month7_Plan": 16277, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 0, | |
| "Month10_Plan": 16277, | |
| "Month10_Patient": 0, | |
| "DrugId": 2 | |
| }, { | |
| "TherapyContinuation_Plan": 176297, | |
| "ProductName": "Afinitor", | |
| "Month11_Patient": 250, | |
| "Lives": 2373, | |
| "TherapyInitiation_Patient": 250, | |
| "DrugTier": "4", | |
| "MedDed": 0, | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 16027, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 16027, | |
| "Month8_Patient": 250, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 16027, | |
| "Month6_Patient": 250, | |
| "TherapyContinuation_Patient": 2750, | |
| "TherapyInitiation_Plan": 16027, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 250, | |
| "Month6_Plan": 16027, | |
| "Month2_Patient": 250, | |
| "Month3_Plan": 16027, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 250, | |
| "CBMax": 250, | |
| "PlanName": "Anthem Gold 80 D EPO", | |
| "Month9_Plan": 16027, | |
| "TotalPlanCost": 192324, | |
| "Month9_Patient": 250, | |
| "MetalLevel": "Gold", | |
| "Month2_Plan": 16027, | |
| "Month8_Plan": 16027, | |
| "Month7_Patient": 250, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6023, | |
| "Month4_Plan": 16027, | |
| "Month5_Patient": 250, | |
| "Month7_Plan": 16027, | |
| "MedOOP": 7200, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 250, | |
| "Month10_Plan": 16027, | |
| "Month10_Patient": 250, | |
| "DrugId": 2 | |
| }, { | |
| "TherapyContinuation_Plan": 179047, | |
| "ProductName": "Afinitor", | |
| "Month11_Patient": 0, | |
| "Lives": 1594, | |
| "TherapyInitiation_Patient": 7900, | |
| "DrugTier": "4", | |
| "MedDed": 7900, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 16277, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 16277, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 16277, | |
| "Month6_Patient": 0, | |
| "TherapyContinuation_Patient": 0, | |
| "TherapyInitiation_Plan": 8377, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 0, | |
| "Month6_Plan": 16277, | |
| "Month2_Patient": 0, | |
| "Month3_Plan": 16277, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "PlanName": "Anthem Minimum Coverage D EPO", | |
| "Month9_Plan": 16277, | |
| "TotalPlanCost": 187424, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Catastrophic", | |
| "Month2_Plan": 16277, | |
| "Month8_Plan": 16277, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6024, | |
| "Month4_Plan": 16277, | |
| "Month5_Patient": 0, | |
| "Month7_Plan": 16277, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 0, | |
| "Month10_Plan": 16277, | |
| "Month10_Patient": 0, | |
| "DrugId": 2 | |
| }, { | |
| "TherapyContinuation_Plan": 176297, | |
| "ProductName": "Afinitor", | |
| "Month11_Patient": 250, | |
| "Lives": 1040, | |
| "TherapyInitiation_Patient": 250, | |
| "DrugTier": "4", | |
| "MedDed": 0, | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 16027, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 16027, | |
| "Month8_Patient": 250, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 16027, | |
| "Month6_Patient": 250, | |
| "TherapyContinuation_Patient": 2750, | |
| "TherapyInitiation_Plan": 16027, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 250, | |
| "Month6_Plan": 16027, | |
| "Month2_Patient": 250, | |
| "Month3_Plan": 16027, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 250, | |
| "CBMax": 250, | |
| "PlanName": "Anthem Platinum 90 D EPO", | |
| "Month9_Plan": 16027, | |
| "TotalPlanCost": 192324, | |
| "Month9_Patient": 250, | |
| "MetalLevel": "Platinum", | |
| "Month2_Plan": 16027, | |
| "Month8_Plan": 16027, | |
| "Month7_Patient": 250, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6025, | |
| "Month4_Plan": 16027, | |
| "Month5_Patient": 250, | |
| "Month7_Plan": 16027, | |
| "MedOOP": 3350, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 250, | |
| "Month10_Plan": 16027, | |
| "Month10_Patient": 250, | |
| "DrugId": 2 | |
| }, { | |
| "TherapyContinuation_Plan": 176297, | |
| "ProductName": "Afinitor", | |
| "RxDed": 200, | |
| "Month11_Patient": 250, | |
| "Lives": 44655, | |
| "TherapyInitiation_Patient": 450, | |
| "DrugTier": "4", | |
| "MedDed": 2500, | |
| "DedType": "Pharmacy", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 16027, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 16027, | |
| "Month8_Patient": 250, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 16027, | |
| "Month6_Patient": 250, | |
| "TherapyContinuation_Patient": 2750, | |
| "TherapyInitiation_Plan": 15827, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 250, | |
| "Month6_Plan": 16027, | |
| "Month2_Patient": 250, | |
| "Month3_Plan": 16027, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 250, | |
| "CBMax": 250, | |
| "PlanName": "Anthem Silver 70 Off Exchange EPO", | |
| "Month9_Plan": 16027, | |
| "TotalPlanCost": 192124, | |
| "Month9_Patient": 250, | |
| "MetalLevel": "Silver", | |
| "Month2_Plan": 16027, | |
| "Month8_Plan": 16027, | |
| "Month7_Patient": 250, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6026, | |
| "Month4_Plan": 16027, | |
| "Month5_Patient": 250, | |
| "Month7_Plan": 16027, | |
| "MedOOP": 7550, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 250, | |
| "Month10_Plan": 16027, | |
| "Month10_Patient": 250, | |
| "DrugId": 2 | |
| }, { | |
| "TherapyContinuation_Plan": 177247, | |
| "ProductName": "Afinitor", | |
| "Month11_Patient": 0, | |
| "Lives": 7081, | |
| "TherapyInitiation_Patient": 6100, | |
| "DrugTier": "4", | |
| "MedDed": 5600, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 15977, | |
| "PlanType": "PPO", | |
| "Month11_Plan": 16277, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 16277, | |
| "Month6_Patient": 0, | |
| "TherapyContinuation_Patient": 1800, | |
| "TherapyInitiation_Plan": 10177, | |
| "TotalTiers": "5", | |
| "Month4_Patient": 500, | |
| "Month6_Plan": 16277, | |
| "Month2_Patient": 500, | |
| "Month3_Plan": 15777, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=9xPV65t4mAk%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze PPO 40/5600/40%", | |
| "Month9_Plan": 16277, | |
| "TotalPlanCost": 187424, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 15777, | |
| "Month8_Plan": 16277, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6027, | |
| "Month4_Plan": 15777, | |
| "Month5_Patient": 300, | |
| "Month7_Plan": 16277, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G (1a/1b), PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 500, | |
| "Month10_Plan": 16277, | |
| "Month10_Patient": 0, | |
| "DrugId": 2 | |
| }]; | |
| export const CABOMETYX = [{ | |
| "TherapyContinuation_Plan": 0, | |
| "ProductName": "Cabometyx", | |
| "RxDed": 500, | |
| "Month11_Patient": 17861, | |
| "Lives": 26088, | |
| "TherapyInitiation_Patient": 17861, | |
| "DrugTier": "Not Covered", | |
| "MedDed": 6300, | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 0, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 0, | |
| "Month8_Patient": 17861, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 0, | |
| "Month6_Patient": 17861, | |
| "TherapyContinuation_Patient": 196471, | |
| "TherapyInitiation_Plan": 0, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 17861, | |
| "Month6_Plan": 0, | |
| "Month2_Patient": 17861, | |
| "Month3_Plan": 0, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 17861, | |
| "PlanName": "Anthem Bronze 60 D EPO", | |
| "Month9_Plan": 0, | |
| "TotalPlanCost": 0, | |
| "Month9_Patient": 17861, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 0, | |
| "Month8_Plan": 0, | |
| "Month7_Patient": 17861, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6018, | |
| "Month4_Plan": 0, | |
| "Month5_Patient": 17861, | |
| "Month7_Plan": 0, | |
| "MedOOP": 7550, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 17861, | |
| "Month10_Plan": 0, | |
| "Month10_Patient": 17861, | |
| "DrugId": 87 | |
| }, { | |
| "TherapyContinuation_Plan": 0, | |
| "ProductName": "Cabometyx", | |
| "Month11_Patient": 17861, | |
| "Lives": 11891, | |
| "TherapyInitiation_Patient": 17861, | |
| "DrugTier": "Not Covered", | |
| "MedDed": 6000, | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 0, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 0, | |
| "Month8_Patient": 17861, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 0, | |
| "Month6_Patient": 17861, | |
| "TherapyContinuation_Patient": 196471, | |
| "TherapyInitiation_Plan": 0, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 17861, | |
| "Month6_Plan": 0, | |
| "Month2_Patient": 17861, | |
| "Month3_Plan": 0, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 17861, | |
| "PlanName": "Anthem Bronze 60 D HDHP EPO", | |
| "Month9_Plan": 0, | |
| "TotalPlanCost": 0, | |
| "Month9_Patient": 17861, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 0, | |
| "Month8_Plan": 0, | |
| "Month7_Patient": 17861, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6019, | |
| "Month4_Plan": 0, | |
| "Month5_Patient": 17861, | |
| "Month7_Plan": 0, | |
| "MedOOP": 6650, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 17861, | |
| "Month10_Plan": 0, | |
| "Month10_Patient": 17861, | |
| "DrugId": 87 | |
| }, { | |
| "TherapyContinuation_Plan": 0, | |
| "ProductName": "Cabometyx", | |
| "Month11_Patient": 17861, | |
| "Lives": 782, | |
| "TherapyInitiation_Patient": 17861, | |
| "DrugTier": "Not Covered", | |
| "MedDed": 5250, | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 0, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 0, | |
| "Month8_Patient": 17861, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 0, | |
| "Month6_Patient": 17861, | |
| "TherapyContinuation_Patient": 196471, | |
| "TherapyInitiation_Plan": 0, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 17861, | |
| "Month6_Plan": 0, | |
| "Month2_Patient": 17861, | |
| "Month3_Plan": 0, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 17861, | |
| "PlanName": "Anthem Bronze Pathway EPO 5250", | |
| "Month9_Plan": 0, | |
| "TotalPlanCost": 0, | |
| "Month9_Patient": 17861, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 0, | |
| "Month8_Plan": 0, | |
| "Month7_Patient": 17861, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6020, | |
| "Month4_Plan": 0, | |
| "Month5_Patient": 17861, | |
| "Month7_Plan": 0, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 17861, | |
| "Month10_Plan": 0, | |
| "Month10_Patient": 17861, | |
| "DrugId": 87 | |
| }, { | |
| "TherapyContinuation_Plan": 0, | |
| "ProductName": "Cabometyx", | |
| "Month11_Patient": 17861, | |
| "Lives": 1773, | |
| "TherapyInitiation_Patient": 17861, | |
| "DrugTier": "Not Covered", | |
| "MedDed": 5850, | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 0, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 0, | |
| "Month8_Patient": 17861, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 0, | |
| "Month6_Patient": 17861, | |
| "TherapyContinuation_Patient": 196471, | |
| "TherapyInitiation_Plan": 0, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 17861, | |
| "Month6_Plan": 0, | |
| "Month2_Patient": 17861, | |
| "Month3_Plan": 0, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 17861, | |
| "PlanName": "Anthem Bronze Pathway EPO 5850", | |
| "Month9_Plan": 0, | |
| "TotalPlanCost": 0, | |
| "Month9_Patient": 17861, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 0, | |
| "Month8_Plan": 0, | |
| "Month7_Patient": 17861, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6021, | |
| "Month4_Plan": 0, | |
| "Month5_Patient": 17861, | |
| "Month7_Plan": 0, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 17861, | |
| "Month10_Plan": 0, | |
| "Month10_Patient": 17861, | |
| "DrugId": 87 | |
| }, { | |
| "TherapyContinuation_Plan": 0, | |
| "ProductName": "Cabometyx", | |
| "Month11_Patient": 17861, | |
| "Lives": 1100, | |
| "TherapyInitiation_Patient": 17861, | |
| "DrugTier": "Not Covered", | |
| "MedDed": 6900, | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 0, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 0, | |
| "Month8_Patient": 17861, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 0, | |
| "Month6_Patient": 17861, | |
| "TherapyContinuation_Patient": 196471, | |
| "TherapyInitiation_Plan": 0, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 17861, | |
| "Month6_Plan": 0, | |
| "Month2_Patient": 17861, | |
| "Month3_Plan": 0, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 17861, | |
| "PlanName": "Anthem Bronze Pathway EPO 6900 Online Plus", | |
| "Month9_Plan": 0, | |
| "TotalPlanCost": 0, | |
| "Month9_Patient": 17861, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 0, | |
| "Month8_Plan": 0, | |
| "Month7_Patient": 17861, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6022, | |
| "Month4_Plan": 0, | |
| "Month5_Patient": 17861, | |
| "Month7_Plan": 0, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 17861, | |
| "Month10_Plan": 0, | |
| "Month10_Patient": 17861, | |
| "DrugId": 87 | |
| }, { | |
| "TherapyContinuation_Plan": 0, | |
| "ProductName": "Cabometyx", | |
| "Month11_Patient": 17861, | |
| "Lives": 2373, | |
| "TherapyInitiation_Patient": 17861, | |
| "DrugTier": "Not Covered", | |
| "MedDed": 0, | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 0, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 0, | |
| "Month8_Patient": 17861, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 0, | |
| "Month6_Patient": 17861, | |
| "TherapyContinuation_Patient": 196471, | |
| "TherapyInitiation_Plan": 0, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 17861, | |
| "Month6_Plan": 0, | |
| "Month2_Patient": 17861, | |
| "Month3_Plan": 0, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 17861, | |
| "PlanName": "Anthem Gold 80 D EPO", | |
| "Month9_Plan": 0, | |
| "TotalPlanCost": 0, | |
| "Month9_Patient": 17861, | |
| "MetalLevel": "Gold", | |
| "Month2_Plan": 0, | |
| "Month8_Plan": 0, | |
| "Month7_Patient": 17861, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6023, | |
| "Month4_Plan": 0, | |
| "Month5_Patient": 17861, | |
| "Month7_Plan": 0, | |
| "MedOOP": 7200, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 17861, | |
| "Month10_Plan": 0, | |
| "Month10_Patient": 17861, | |
| "DrugId": 87 | |
| }, { | |
| "TherapyContinuation_Plan": 0, | |
| "ProductName": "Cabometyx", | |
| "Month11_Patient": 17861, | |
| "Lives": 1594, | |
| "TherapyInitiation_Patient": 17861, | |
| "DrugTier": "Not Covered", | |
| "MedDed": 7900, | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 0, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 0, | |
| "Month8_Patient": 17861, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 0, | |
| "Month6_Patient": 17861, | |
| "TherapyContinuation_Patient": 196471, | |
| "TherapyInitiation_Plan": 0, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 17861, | |
| "Month6_Plan": 0, | |
| "Month2_Patient": 17861, | |
| "Month3_Plan": 0, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 17861, | |
| "PlanName": "Anthem Minimum Coverage D EPO", | |
| "Month9_Plan": 0, | |
| "TotalPlanCost": 0, | |
| "Month9_Patient": 17861, | |
| "MetalLevel": "Catastrophic", | |
| "Month2_Plan": 0, | |
| "Month8_Plan": 0, | |
| "Month7_Patient": 17861, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6024, | |
| "Month4_Plan": 0, | |
| "Month5_Patient": 17861, | |
| "Month7_Plan": 0, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 17861, | |
| "Month10_Plan": 0, | |
| "Month10_Patient": 17861, | |
| "DrugId": 87 | |
| }, { | |
| "TherapyContinuation_Plan": 0, | |
| "ProductName": "Cabometyx", | |
| "Month11_Patient": 17861, | |
| "Lives": 1040, | |
| "TherapyInitiation_Patient": 17861, | |
| "DrugTier": "Not Covered", | |
| "MedDed": 0, | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 0, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 0, | |
| "Month8_Patient": 17861, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 0, | |
| "Month6_Patient": 17861, | |
| "TherapyContinuation_Patient": 196471, | |
| "TherapyInitiation_Plan": 0, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 17861, | |
| "Month6_Plan": 0, | |
| "Month2_Patient": 17861, | |
| "Month3_Plan": 0, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 17861, | |
| "PlanName": "Anthem Platinum 90 D EPO", | |
| "Month9_Plan": 0, | |
| "TotalPlanCost": 0, | |
| "Month9_Patient": 17861, | |
| "MetalLevel": "Platinum", | |
| "Month2_Plan": 0, | |
| "Month8_Plan": 0, | |
| "Month7_Patient": 17861, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6025, | |
| "Month4_Plan": 0, | |
| "Month5_Patient": 17861, | |
| "Month7_Plan": 0, | |
| "MedOOP": 3350, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 17861, | |
| "Month10_Plan": 0, | |
| "Month10_Patient": 17861, | |
| "DrugId": 87 | |
| }, { | |
| "TherapyContinuation_Plan": 0, | |
| "ProductName": "Cabometyx", | |
| "RxDed": 200, | |
| "Month11_Patient": 17861, | |
| "Lives": 44655, | |
| "TherapyInitiation_Patient": 17861, | |
| "DrugTier": "Not Covered", | |
| "MedDed": 2500, | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 0, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 0, | |
| "Month8_Patient": 17861, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 0, | |
| "Month6_Patient": 17861, | |
| "TherapyContinuation_Patient": 196471, | |
| "TherapyInitiation_Plan": 0, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 17861, | |
| "Month6_Plan": 0, | |
| "Month2_Patient": 17861, | |
| "Month3_Plan": 0, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 17861, | |
| "PlanName": "Anthem Silver 70 Off Exchange EPO", | |
| "Month9_Plan": 0, | |
| "TotalPlanCost": 0, | |
| "Month9_Patient": 17861, | |
| "MetalLevel": "Silver", | |
| "Month2_Plan": 0, | |
| "Month8_Plan": 0, | |
| "Month7_Patient": 17861, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6026, | |
| "Month4_Plan": 0, | |
| "Month5_Patient": 17861, | |
| "Month7_Plan": 0, | |
| "MedOOP": 7550, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 17861, | |
| "Month10_Plan": 0, | |
| "Month10_Patient": 17861, | |
| "DrugId": 87 | |
| }, { | |
| "TherapyContinuation_Plan": 0, | |
| "ProductName": "Cabometyx", | |
| "Month11_Patient": 17861, | |
| "Lives": 7081, | |
| "TherapyInitiation_Patient": 17861, | |
| "DrugTier": "Not Covered", | |
| "MedDed": 5600, | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 0, | |
| "PlanType": "PPO", | |
| "Month11_Plan": 0, | |
| "Month8_Patient": 17861, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 0, | |
| "Month6_Patient": 17861, | |
| "TherapyContinuation_Patient": 196471, | |
| "TherapyInitiation_Plan": 0, | |
| "TotalTiers": "5", | |
| "Month4_Patient": 17861, | |
| "Month6_Plan": 0, | |
| "Month2_Patient": 17861, | |
| "Month3_Plan": 0, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=9xPV65t4mAk%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 17861, | |
| "PlanName": "Anthem Bronze PPO 40/5600/40%", | |
| "Month9_Plan": 0, | |
| "TotalPlanCost": 0, | |
| "Month9_Patient": 17861, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 0, | |
| "Month8_Plan": 0, | |
| "Month7_Patient": 17861, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6027, | |
| "Month4_Plan": 0, | |
| "Month5_Patient": 17861, | |
| "Month7_Plan": 0, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G (1a/1b), PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 17861, | |
| "Month10_Plan": 0, | |
| "Month10_Patient": 17861, | |
| "DrugId": 87 | |
| }]; | |
| export const INLYTA = [{ | |
| "TherapyContinuation_Plan": 144980, | |
| "ProductName": "Inlyta", | |
| "RxDed": 500, | |
| "Month11_Patient": 500, | |
| "Lives": 26088, | |
| "TherapyInitiation_Patient": 1000, | |
| "DrugTier": "4", | |
| "MedDed": 6300, | |
| "DedType": "Pharmacy", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 13180, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 13180, | |
| "Month8_Patient": 500, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 13180, | |
| "Month6_Patient": 500, | |
| "TherapyContinuation_Patient": 5500, | |
| "TherapyInitiation_Plan": 12680, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 500, | |
| "Month6_Plan": 13180, | |
| "Month2_Patient": 500, | |
| "Month3_Plan": 13180, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 500, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze 60 D EPO", | |
| "Month9_Plan": 13180, | |
| "TotalPlanCost": 157660, | |
| "Month9_Patient": 500, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 13180, | |
| "Month8_Plan": 13180, | |
| "Month7_Patient": 500, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6018, | |
| "Month4_Plan": 13180, | |
| "Month5_Patient": 500, | |
| "Month7_Plan": 13180, | |
| "MedOOP": 7550, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 500, | |
| "Month10_Plan": 13180, | |
| "Month10_Patient": 500, | |
| "DrugId": 64 | |
| }, { | |
| "TherapyContinuation_Plan": 150330, | |
| "ProductName": "Inlyta", | |
| "Month11_Patient": 0, | |
| "Lives": 11891, | |
| "TherapyInitiation_Patient": 6500, | |
| "DrugTier": "4", | |
| "MedDed": 6000, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 13680, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 13680, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 13680, | |
| "Month6_Patient": 0, | |
| "TherapyContinuation_Patient": 150, | |
| "TherapyInitiation_Plan": 7180, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 0, | |
| "Month6_Plan": 13680, | |
| "Month2_Patient": 150, | |
| "Month3_Plan": 13680, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze 60 D HDHP EPO", | |
| "Month9_Plan": 13680, | |
| "TotalPlanCost": 157510, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 13530, | |
| "Month8_Plan": 13680, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6019, | |
| "Month4_Plan": 13680, | |
| "Month5_Patient": 0, | |
| "Month7_Plan": 13680, | |
| "MedOOP": 6650, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 0, | |
| "Month10_Plan": 13680, | |
| "Month10_Patient": 0, | |
| "DrugId": 64 | |
| }, { | |
| "TherapyContinuation_Plan": 148330, | |
| "ProductName": "Inlyta", | |
| "Month11_Patient": 0, | |
| "Lives": 782, | |
| "TherapyInitiation_Patient": 5750, | |
| "DrugTier": "4", | |
| "MedDed": 5250, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 13180, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 13680, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 13680, | |
| "Month6_Patient": 150, | |
| "TherapyContinuation_Patient": 2150, | |
| "TherapyInitiation_Plan": 7930, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 500, | |
| "Month6_Plan": 13530, | |
| "Month2_Patient": 500, | |
| "Month3_Plan": 13180, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze Pathway EPO 5250", | |
| "Month9_Plan": 13680, | |
| "TotalPlanCost": 156260, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 13180, | |
| "Month8_Plan": 13680, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6020, | |
| "Month4_Plan": 13180, | |
| "Month5_Patient": 500, | |
| "Month7_Plan": 13680, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 500, | |
| "Month10_Plan": 13680, | |
| "Month10_Patient": 0, | |
| "DrugId": 64 | |
| }, { | |
| "TherapyContinuation_Plan": 148930, | |
| "ProductName": "Inlyta", | |
| "Month11_Patient": 0, | |
| "Lives": 1773, | |
| "TherapyInitiation_Patient": 6350, | |
| "DrugTier": "4", | |
| "MedDed": 5850, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 13630, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 13680, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 13680, | |
| "Month6_Patient": 0, | |
| "TherapyContinuation_Patient": 1550, | |
| "TherapyInitiation_Plan": 7330, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 500, | |
| "Month6_Plan": 13680, | |
| "Month2_Patient": 500, | |
| "Month3_Plan": 13180, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze Pathway EPO 5850", | |
| "Month9_Plan": 13680, | |
| "TotalPlanCost": 156260, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 13180, | |
| "Month8_Plan": 13680, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6021, | |
| "Month4_Plan": 13180, | |
| "Month5_Patient": 50, | |
| "Month7_Plan": 13680, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 500, | |
| "Month10_Plan": 13680, | |
| "Month10_Patient": 0, | |
| "DrugId": 64 | |
| }, { | |
| "TherapyContinuation_Plan": 149980, | |
| "ProductName": "Inlyta", | |
| "Month11_Patient": 0, | |
| "Lives": 1100, | |
| "TherapyInitiation_Patient": 7400, | |
| "DrugTier": "4", | |
| "MedDed": 6900, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 13680, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 13680, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 13680, | |
| "Month6_Patient": 0, | |
| "TherapyContinuation_Patient": 500, | |
| "TherapyInitiation_Plan": 6280, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 0, | |
| "Month6_Plan": 13680, | |
| "Month2_Patient": 500, | |
| "Month3_Plan": 13680, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze Pathway EPO 6900 Online Plus", | |
| "Month9_Plan": 13680, | |
| "TotalPlanCost": 156260, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 13180, | |
| "Month8_Plan": 13680, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6022, | |
| "Month4_Plan": 13680, | |
| "Month5_Patient": 0, | |
| "Month7_Plan": 13680, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 0, | |
| "Month10_Plan": 13680, | |
| "Month10_Patient": 0, | |
| "DrugId": 64 | |
| }, { | |
| "TherapyContinuation_Plan": 147730, | |
| "ProductName": "Inlyta", | |
| "Month11_Patient": 250, | |
| "Lives": 2373, | |
| "TherapyInitiation_Patient": 250, | |
| "DrugTier": "4", | |
| "MedDed": 0, | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 13430, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 13430, | |
| "Month8_Patient": 250, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 13430, | |
| "Month6_Patient": 250, | |
| "TherapyContinuation_Patient": 2750, | |
| "TherapyInitiation_Plan": 13430, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 250, | |
| "Month6_Plan": 13430, | |
| "Month2_Patient": 250, | |
| "Month3_Plan": 13430, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 250, | |
| "CBMax": 250, | |
| "PlanName": "Anthem Gold 80 D EPO", | |
| "Month9_Plan": 13430, | |
| "TotalPlanCost": 161160, | |
| "Month9_Patient": 250, | |
| "MetalLevel": "Gold", | |
| "Month2_Plan": 13430, | |
| "Month8_Plan": 13430, | |
| "Month7_Patient": 250, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6023, | |
| "Month4_Plan": 13430, | |
| "Month5_Patient": 250, | |
| "Month7_Plan": 13430, | |
| "MedOOP": 7200, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 250, | |
| "Month10_Plan": 13430, | |
| "Month10_Patient": 250, | |
| "DrugId": 64 | |
| }, { | |
| "TherapyContinuation_Plan": 150480, | |
| "ProductName": "Inlyta", | |
| "Month11_Patient": 0, | |
| "Lives": 1594, | |
| "TherapyInitiation_Patient": 7900, | |
| "DrugTier": "4", | |
| "MedDed": 7900, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 13680, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 13680, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 13680, | |
| "Month6_Patient": 0, | |
| "TherapyContinuation_Patient": 0, | |
| "TherapyInitiation_Plan": 5780, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 0, | |
| "Month6_Plan": 13680, | |
| "Month2_Patient": 0, | |
| "Month3_Plan": 13680, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "PlanName": "Anthem Minimum Coverage D EPO", | |
| "Month9_Plan": 13680, | |
| "TotalPlanCost": 156260, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Catastrophic", | |
| "Month2_Plan": 13680, | |
| "Month8_Plan": 13680, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6024, | |
| "Month4_Plan": 13680, | |
| "Month5_Patient": 0, | |
| "Month7_Plan": 13680, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 0, | |
| "Month10_Plan": 13680, | |
| "Month10_Patient": 0, | |
| "DrugId": 64 | |
| }, { | |
| "TherapyContinuation_Plan": 147730, | |
| "ProductName": "Inlyta", | |
| "Month11_Patient": 250, | |
| "Lives": 1040, | |
| "TherapyInitiation_Patient": 250, | |
| "DrugTier": "4", | |
| "MedDed": 0, | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 13430, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 13430, | |
| "Month8_Patient": 250, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 13430, | |
| "Month6_Patient": 250, | |
| "TherapyContinuation_Patient": 2750, | |
| "TherapyInitiation_Plan": 13430, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 250, | |
| "Month6_Plan": 13430, | |
| "Month2_Patient": 250, | |
| "Month3_Plan": 13430, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 250, | |
| "CBMax": 250, | |
| "PlanName": "Anthem Platinum 90 D EPO", | |
| "Month9_Plan": 13430, | |
| "TotalPlanCost": 161160, | |
| "Month9_Patient": 250, | |
| "MetalLevel": "Platinum", | |
| "Month2_Plan": 13430, | |
| "Month8_Plan": 13430, | |
| "Month7_Patient": 250, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6025, | |
| "Month4_Plan": 13430, | |
| "Month5_Patient": 250, | |
| "Month7_Plan": 13430, | |
| "MedOOP": 3350, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 250, | |
| "Month10_Plan": 13430, | |
| "Month10_Patient": 250, | |
| "DrugId": 64 | |
| }, { | |
| "TherapyContinuation_Plan": 147730, | |
| "ProductName": "Inlyta", | |
| "RxDed": 200, | |
| "Month11_Patient": 250, | |
| "Lives": 44655, | |
| "TherapyInitiation_Patient": 450, | |
| "DrugTier": "4", | |
| "MedDed": 2500, | |
| "DedType": "Pharmacy", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 13430, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 13430, | |
| "Month8_Patient": 250, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 13430, | |
| "Month6_Patient": 250, | |
| "TherapyContinuation_Patient": 2750, | |
| "TherapyInitiation_Plan": 13230, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 250, | |
| "Month6_Plan": 13430, | |
| "Month2_Patient": 250, | |
| "Month3_Plan": 13430, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 250, | |
| "CBMax": 250, | |
| "PlanName": "Anthem Silver 70 Off Exchange EPO", | |
| "Month9_Plan": 13430, | |
| "TotalPlanCost": 160960, | |
| "Month9_Patient": 250, | |
| "MetalLevel": "Silver", | |
| "Month2_Plan": 13430, | |
| "Month8_Plan": 13430, | |
| "Month7_Patient": 250, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6026, | |
| "Month4_Plan": 13430, | |
| "Month5_Patient": 250, | |
| "Month7_Plan": 13430, | |
| "MedOOP": 7550, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 250, | |
| "Month10_Plan": 13430, | |
| "Month10_Patient": 250, | |
| "DrugId": 64 | |
| }, { | |
| "TherapyContinuation_Plan": 148680, | |
| "ProductName": "Inlyta", | |
| "Month11_Patient": 0, | |
| "Lives": 7081, | |
| "TherapyInitiation_Patient": 6100, | |
| "DrugTier": "4", | |
| "MedDed": 5600, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 13380, | |
| "PlanType": "PPO", | |
| "Month11_Plan": 13680, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 13680, | |
| "Month6_Patient": 0, | |
| "TherapyContinuation_Patient": 1800, | |
| "TherapyInitiation_Plan": 7580, | |
| "TotalTiers": "5", | |
| "Month4_Patient": 500, | |
| "Month6_Plan": 13680, | |
| "Month2_Patient": 500, | |
| "Month3_Plan": 13180, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=9xPV65t4mAk%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze PPO 40/5600/40%", | |
| "Month9_Plan": 13680, | |
| "TotalPlanCost": 156260, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 13180, | |
| "Month8_Plan": 13680, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6027, | |
| "Month4_Plan": 13180, | |
| "Month5_Patient": 300, | |
| "Month7_Plan": 13680, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G (1a/1b), PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 500, | |
| "Month10_Plan": 13680, | |
| "Month10_Patient": 0, | |
| "DrugId": 64 | |
| }]; | |
| export const LENVIMA = [{ | |
| "TherapyContinuation_Plan": 196218, | |
| "ProductName": "Lenvima", | |
| "RxDed": 500, | |
| "Month11_Patient": 500, | |
| "Lives": 26088, | |
| "TherapyInitiation_Patient": 1000, | |
| "DrugTier": "4", | |
| "MedDed": 6300, | |
| "DedType": "Pharmacy", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 17838, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 17838, | |
| "Month8_Patient": 500, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 17838, | |
| "Month6_Patient": 500, | |
| "TherapyContinuation_Patient": 5500, | |
| "TherapyInitiation_Plan": 17338, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 500, | |
| "Month6_Plan": 17838, | |
| "Month2_Patient": 500, | |
| "Month3_Plan": 17838, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 500, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze 60 D EPO", | |
| "Month9_Plan": 17838, | |
| "TotalPlanCost": 213556, | |
| "Month9_Patient": 500, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 17838, | |
| "Month8_Plan": 17838, | |
| "Month7_Patient": 500, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6018, | |
| "Month4_Plan": 17838, | |
| "Month5_Patient": 500, | |
| "Month7_Plan": 17838, | |
| "MedOOP": 7550, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 500, | |
| "Month10_Plan": 17838, | |
| "Month10_Patient": 500, | |
| "DrugId": 104 | |
| }, { | |
| "TherapyContinuation_Plan": 201568, | |
| "ProductName": "Lenvima", | |
| "Month11_Patient": 0, | |
| "Lives": 11891, | |
| "TherapyInitiation_Patient": 6500, | |
| "DrugTier": "4", | |
| "MedDed": 6000, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 18338, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 18338, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 18338, | |
| "Month6_Patient": 0, | |
| "TherapyContinuation_Patient": 150, | |
| "TherapyInitiation_Plan": 11838, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 0, | |
| "Month6_Plan": 18338, | |
| "Month2_Patient": 150, | |
| "Month3_Plan": 18338, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze 60 D HDHP EPO", | |
| "Month9_Plan": 18338, | |
| "TotalPlanCost": 213406, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 18188, | |
| "Month8_Plan": 18338, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6019, | |
| "Month4_Plan": 18338, | |
| "Month5_Patient": 0, | |
| "Month7_Plan": 18338, | |
| "MedOOP": 6650, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 0, | |
| "Month10_Plan": 18338, | |
| "Month10_Patient": 0, | |
| "DrugId": 104 | |
| }, { | |
| "TherapyContinuation_Plan": 199568, | |
| "ProductName": "Lenvima", | |
| "Month11_Patient": 0, | |
| "Lives": 782, | |
| "TherapyInitiation_Patient": 5750, | |
| "DrugTier": "4", | |
| "MedDed": 5250, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 17838, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 18338, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 18338, | |
| "Month6_Patient": 150, | |
| "TherapyContinuation_Patient": 2150, | |
| "TherapyInitiation_Plan": 12588, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 500, | |
| "Month6_Plan": 18188, | |
| "Month2_Patient": 500, | |
| "Month3_Plan": 17838, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze Pathway EPO 5250", | |
| "Month9_Plan": 18338, | |
| "TotalPlanCost": 212156, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 17838, | |
| "Month8_Plan": 18338, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6020, | |
| "Month4_Plan": 17838, | |
| "Month5_Patient": 500, | |
| "Month7_Plan": 18338, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 500, | |
| "Month10_Plan": 18338, | |
| "Month10_Patient": 0, | |
| "DrugId": 104 | |
| }, { | |
| "TherapyContinuation_Plan": 200168, | |
| "ProductName": "Lenvima", | |
| "Month11_Patient": 0, | |
| "Lives": 1773, | |
| "TherapyInitiation_Patient": 6350, | |
| "DrugTier": "4", | |
| "MedDed": 5850, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 18288, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 18338, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 18338, | |
| "Month6_Patient": 0, | |
| "TherapyContinuation_Patient": 1550, | |
| "TherapyInitiation_Plan": 11988, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 500, | |
| "Month6_Plan": 18338, | |
| "Month2_Patient": 500, | |
| "Month3_Plan": 17838, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze Pathway EPO 5850", | |
| "Month9_Plan": 18338, | |
| "TotalPlanCost": 212156, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 17838, | |
| "Month8_Plan": 18338, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6021, | |
| "Month4_Plan": 17838, | |
| "Month5_Patient": 50, | |
| "Month7_Plan": 18338, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 500, | |
| "Month10_Plan": 18338, | |
| "Month10_Patient": 0, | |
| "DrugId": 104 | |
| }, { | |
| "TherapyContinuation_Plan": 201218, | |
| "ProductName": "Lenvima", | |
| "Month11_Patient": 0, | |
| "Lives": 1100, | |
| "TherapyInitiation_Patient": 7400, | |
| "DrugTier": "4", | |
| "MedDed": 6900, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 18338, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 18338, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 18338, | |
| "Month6_Patient": 0, | |
| "TherapyContinuation_Patient": 500, | |
| "TherapyInitiation_Plan": 10938, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 0, | |
| "Month6_Plan": 18338, | |
| "Month2_Patient": 500, | |
| "Month3_Plan": 18338, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze Pathway EPO 6900 Online Plus", | |
| "Month9_Plan": 18338, | |
| "TotalPlanCost": 212156, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 17838, | |
| "Month8_Plan": 18338, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6022, | |
| "Month4_Plan": 18338, | |
| "Month5_Patient": 0, | |
| "Month7_Plan": 18338, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 0, | |
| "Month10_Plan": 18338, | |
| "Month10_Patient": 0, | |
| "DrugId": 104 | |
| }, { | |
| "TherapyContinuation_Plan": 198968, | |
| "ProductName": "Lenvima", | |
| "Month11_Patient": 250, | |
| "Lives": 2373, | |
| "TherapyInitiation_Patient": 250, | |
| "DrugTier": "4", | |
| "MedDed": 0, | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 18088, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 18088, | |
| "Month8_Patient": 250, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 18088, | |
| "Month6_Patient": 250, | |
| "TherapyContinuation_Patient": 2750, | |
| "TherapyInitiation_Plan": 18088, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 250, | |
| "Month6_Plan": 18088, | |
| "Month2_Patient": 250, | |
| "Month3_Plan": 18088, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 250, | |
| "CBMax": 250, | |
| "PlanName": "Anthem Gold 80 D EPO", | |
| "Month9_Plan": 18088, | |
| "TotalPlanCost": 217056, | |
| "Month9_Patient": 250, | |
| "MetalLevel": "Gold", | |
| "Month2_Plan": 18088, | |
| "Month8_Plan": 18088, | |
| "Month7_Patient": 250, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6023, | |
| "Month4_Plan": 18088, | |
| "Month5_Patient": 250, | |
| "Month7_Plan": 18088, | |
| "MedOOP": 7200, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 250, | |
| "Month10_Plan": 18088, | |
| "Month10_Patient": 250, | |
| "DrugId": 104 | |
| }, { | |
| "TherapyContinuation_Plan": 201718, | |
| "ProductName": "Lenvima", | |
| "Month11_Patient": 0, | |
| "Lives": 1594, | |
| "TherapyInitiation_Patient": 7900, | |
| "DrugTier": "4", | |
| "MedDed": 7900, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 18338, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 18338, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 18338, | |
| "Month6_Patient": 0, | |
| "TherapyContinuation_Patient": 0, | |
| "TherapyInitiation_Plan": 10438, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 0, | |
| "Month6_Plan": 18338, | |
| "Month2_Patient": 0, | |
| "Month3_Plan": 18338, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "PlanName": "Anthem Minimum Coverage D EPO", | |
| "Month9_Plan": 18338, | |
| "TotalPlanCost": 212156, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Catastrophic", | |
| "Month2_Plan": 18338, | |
| "Month8_Plan": 18338, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6024, | |
| "Month4_Plan": 18338, | |
| "Month5_Patient": 0, | |
| "Month7_Plan": 18338, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 0, | |
| "Month10_Plan": 18338, | |
| "Month10_Patient": 0, | |
| "DrugId": 104 | |
| }, { | |
| "TherapyContinuation_Plan": 198968, | |
| "ProductName": "Lenvima", | |
| "Month11_Patient": 250, | |
| "Lives": 1040, | |
| "TherapyInitiation_Patient": 250, | |
| "DrugTier": "4", | |
| "MedDed": 0, | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 18088, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 18088, | |
| "Month8_Patient": 250, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 18088, | |
| "Month6_Patient": 250, | |
| "TherapyContinuation_Patient": 2750, | |
| "TherapyInitiation_Plan": 18088, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 250, | |
| "Month6_Plan": 18088, | |
| "Month2_Patient": 250, | |
| "Month3_Plan": 18088, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 250, | |
| "CBMax": 250, | |
| "PlanName": "Anthem Platinum 90 D EPO", | |
| "Month9_Plan": 18088, | |
| "TotalPlanCost": 217056, | |
| "Month9_Patient": 250, | |
| "MetalLevel": "Platinum", | |
| "Month2_Plan": 18088, | |
| "Month8_Plan": 18088, | |
| "Month7_Patient": 250, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6025, | |
| "Month4_Plan": 18088, | |
| "Month5_Patient": 250, | |
| "Month7_Plan": 18088, | |
| "MedOOP": 3350, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 250, | |
| "Month10_Plan": 18088, | |
| "Month10_Patient": 250, | |
| "DrugId": 104 | |
| }, { | |
| "TherapyContinuation_Plan": 198968, | |
| "ProductName": "Lenvima", | |
| "RxDed": 200, | |
| "Month11_Patient": 250, | |
| "Lives": 44655, | |
| "TherapyInitiation_Patient": 450, | |
| "DrugTier": "4", | |
| "MedDed": 2500, | |
| "DedType": "Pharmacy", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 18088, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 18088, | |
| "Month8_Patient": 250, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 18088, | |
| "Month6_Patient": 250, | |
| "TherapyContinuation_Patient": 2750, | |
| "TherapyInitiation_Plan": 17888, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 250, | |
| "Month6_Plan": 18088, | |
| "Month2_Patient": 250, | |
| "Month3_Plan": 18088, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 250, | |
| "CBMax": 250, | |
| "PlanName": "Anthem Silver 70 Off Exchange EPO", | |
| "Month9_Plan": 18088, | |
| "TotalPlanCost": 216856, | |
| "Month9_Patient": 250, | |
| "MetalLevel": "Silver", | |
| "Month2_Plan": 18088, | |
| "Month8_Plan": 18088, | |
| "Month7_Patient": 250, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6026, | |
| "Month4_Plan": 18088, | |
| "Month5_Patient": 250, | |
| "Month7_Plan": 18088, | |
| "MedOOP": 7550, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 250, | |
| "Month10_Plan": 18088, | |
| "Month10_Patient": 250, | |
| "DrugId": 104 | |
| }, { | |
| "TherapyContinuation_Plan": 199918, | |
| "ProductName": "Lenvima", | |
| "Month11_Patient": 0, | |
| "Lives": 7081, | |
| "TherapyInitiation_Patient": 6100, | |
| "DrugTier": "4", | |
| "MedDed": 5600, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 18038, | |
| "PlanType": "PPO", | |
| "Month11_Plan": 18338, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 18338, | |
| "Month6_Patient": 0, | |
| "TherapyContinuation_Patient": 1800, | |
| "TherapyInitiation_Plan": 12238, | |
| "TotalTiers": "5", | |
| "Month4_Patient": 500, | |
| "Month6_Plan": 18338, | |
| "Month2_Patient": 500, | |
| "Month3_Plan": 17838, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=9xPV65t4mAk%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze PPO 40/5600/40%", | |
| "Month9_Plan": 18338, | |
| "TotalPlanCost": 212156, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 17838, | |
| "Month8_Plan": 18338, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6027, | |
| "Month4_Plan": 17838, | |
| "Month5_Patient": 300, | |
| "Month7_Plan": 18338, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G (1a/1b), PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 500, | |
| "Month10_Plan": 18338, | |
| "Month10_Patient": 0, | |
| "DrugId": 104 | |
| }]; | |
| export const NEXAVAR = [{ | |
| "TherapyContinuation_Plan": 209033, | |
| "ProductName": "Nexavar", | |
| "RxDed": 500, | |
| "Month11_Patient": 500, | |
| "Lives": 26088, | |
| "TherapyInitiation_Patient": 1000, | |
| "DrugTier": "4", | |
| "MedDed": 6300, | |
| "DedType": "Pharmacy", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 19003, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 19003, | |
| "Month8_Patient": 500, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 19003, | |
| "Month6_Patient": 500, | |
| "TherapyContinuation_Patient": 5500, | |
| "TherapyInitiation_Plan": 18503, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 500, | |
| "Month6_Plan": 19003, | |
| "Month2_Patient": 500, | |
| "Month3_Plan": 19003, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 500, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze 60 D EPO", | |
| "Month9_Plan": 19003, | |
| "TotalPlanCost": 227536, | |
| "Month9_Patient": 500, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 19003, | |
| "Month8_Plan": 19003, | |
| "Month7_Patient": 500, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6018, | |
| "Month4_Plan": 19003, | |
| "Month5_Patient": 500, | |
| "Month7_Plan": 19003, | |
| "MedOOP": 7550, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 500, | |
| "Month10_Plan": 19003, | |
| "Month10_Patient": 500, | |
| "DrugId": 65 | |
| }, { | |
| "TherapyContinuation_Plan": 214383, | |
| "ProductName": "Nexavar", | |
| "Month11_Patient": 0, | |
| "Lives": 11891, | |
| "TherapyInitiation_Patient": 6500, | |
| "DrugTier": "4", | |
| "MedDed": 6000, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 19503, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 19503, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 19503, | |
| "Month6_Patient": 0, | |
| "TherapyContinuation_Patient": 150, | |
| "TherapyInitiation_Plan": 13003, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 0, | |
| "Month6_Plan": 19503, | |
| "Month2_Patient": 150, | |
| "Month3_Plan": 19503, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze 60 D HDHP EPO", | |
| "Month9_Plan": 19503, | |
| "TotalPlanCost": 227386, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 19353, | |
| "Month8_Plan": 19503, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6019, | |
| "Month4_Plan": 19503, | |
| "Month5_Patient": 0, | |
| "Month7_Plan": 19503, | |
| "MedOOP": 6650, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 0, | |
| "Month10_Plan": 19503, | |
| "Month10_Patient": 0, | |
| "DrugId": 65 | |
| }, { | |
| "TherapyContinuation_Plan": 212383, | |
| "ProductName": "Nexavar", | |
| "Month11_Patient": 0, | |
| "Lives": 782, | |
| "TherapyInitiation_Patient": 5750, | |
| "DrugTier": "4", | |
| "MedDed": 5250, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 19003, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 19503, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 19503, | |
| "Month6_Patient": 150, | |
| "TherapyContinuation_Patient": 2150, | |
| "TherapyInitiation_Plan": 13753, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 500, | |
| "Month6_Plan": 19353, | |
| "Month2_Patient": 500, | |
| "Month3_Plan": 19003, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze Pathway EPO 5250", | |
| "Month9_Plan": 19503, | |
| "TotalPlanCost": 226136, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 19003, | |
| "Month8_Plan": 19503, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6020, | |
| "Month4_Plan": 19003, | |
| "Month5_Patient": 500, | |
| "Month7_Plan": 19503, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 500, | |
| "Month10_Plan": 19503, | |
| "Month10_Patient": 0, | |
| "DrugId": 65 | |
| }, { | |
| "TherapyContinuation_Plan": 212983, | |
| "ProductName": "Nexavar", | |
| "Month11_Patient": 0, | |
| "Lives": 1773, | |
| "TherapyInitiation_Patient": 6350, | |
| "DrugTier": "4", | |
| "MedDed": 5850, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 19453, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 19503, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 19503, | |
| "Month6_Patient": 0, | |
| "TherapyContinuation_Patient": 1550, | |
| "TherapyInitiation_Plan": 13153, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 500, | |
| "Month6_Plan": 19503, | |
| "Month2_Patient": 500, | |
| "Month3_Plan": 19003, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze Pathway EPO 5850", | |
| "Month9_Plan": 19503, | |
| "TotalPlanCost": 226136, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 19003, | |
| "Month8_Plan": 19503, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6021, | |
| "Month4_Plan": 19003, | |
| "Month5_Patient": 50, | |
| "Month7_Plan": 19503, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 500, | |
| "Month10_Plan": 19503, | |
| "Month10_Patient": 0, | |
| "DrugId": 65 | |
| }, { | |
| "TherapyContinuation_Plan": 214033, | |
| "ProductName": "Nexavar", | |
| "Month11_Patient": 0, | |
| "Lives": 1100, | |
| "TherapyInitiation_Patient": 7400, | |
| "DrugTier": "4", | |
| "MedDed": 6900, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 19503, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 19503, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 19503, | |
| "Month6_Patient": 0, | |
| "TherapyContinuation_Patient": 500, | |
| "TherapyInitiation_Plan": 12103, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 0, | |
| "Month6_Plan": 19503, | |
| "Month2_Patient": 500, | |
| "Month3_Plan": 19503, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze Pathway EPO 6900 Online Plus", | |
| "Month9_Plan": 19503, | |
| "TotalPlanCost": 226136, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 19003, | |
| "Month8_Plan": 19503, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6022, | |
| "Month4_Plan": 19503, | |
| "Month5_Patient": 0, | |
| "Month7_Plan": 19503, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 0, | |
| "Month10_Plan": 19503, | |
| "Month10_Patient": 0, | |
| "DrugId": 65 | |
| }, { | |
| "TherapyContinuation_Plan": 211783, | |
| "ProductName": "Nexavar", | |
| "Month11_Patient": 250, | |
| "Lives": 2373, | |
| "TherapyInitiation_Patient": 250, | |
| "DrugTier": "4", | |
| "MedDed": 0, | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 19253, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 19253, | |
| "Month8_Patient": 250, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 19253, | |
| "Month6_Patient": 250, | |
| "TherapyContinuation_Patient": 2750, | |
| "TherapyInitiation_Plan": 19253, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 250, | |
| "Month6_Plan": 19253, | |
| "Month2_Patient": 250, | |
| "Month3_Plan": 19253, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 250, | |
| "CBMax": 250, | |
| "PlanName": "Anthem Gold 80 D EPO", | |
| "Month9_Plan": 19253, | |
| "TotalPlanCost": 231036, | |
| "Month9_Patient": 250, | |
| "MetalLevel": "Gold", | |
| "Month2_Plan": 19253, | |
| "Month8_Plan": 19253, | |
| "Month7_Patient": 250, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6023, | |
| "Month4_Plan": 19253, | |
| "Month5_Patient": 250, | |
| "Month7_Plan": 19253, | |
| "MedOOP": 7200, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 250, | |
| "Month10_Plan": 19253, | |
| "Month10_Patient": 250, | |
| "DrugId": 65 | |
| }, { | |
| "TherapyContinuation_Plan": 214533, | |
| "ProductName": "Nexavar", | |
| "Month11_Patient": 0, | |
| "Lives": 1594, | |
| "TherapyInitiation_Patient": 7900, | |
| "DrugTier": "4", | |
| "MedDed": 7900, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 19503, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 19503, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 19503, | |
| "Month6_Patient": 0, | |
| "TherapyContinuation_Patient": 0, | |
| "TherapyInitiation_Plan": 11603, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 0, | |
| "Month6_Plan": 19503, | |
| "Month2_Patient": 0, | |
| "Month3_Plan": 19503, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "PlanName": "Anthem Minimum Coverage D EPO", | |
| "Month9_Plan": 19503, | |
| "TotalPlanCost": 226136, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Catastrophic", | |
| "Month2_Plan": 19503, | |
| "Month8_Plan": 19503, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6024, | |
| "Month4_Plan": 19503, | |
| "Month5_Patient": 0, | |
| "Month7_Plan": 19503, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 0, | |
| "Month10_Plan": 19503, | |
| "Month10_Patient": 0, | |
| "DrugId": 65 | |
| }, { | |
| "TherapyContinuation_Plan": 211783, | |
| "ProductName": "Nexavar", | |
| "Month11_Patient": 250, | |
| "Lives": 1040, | |
| "TherapyInitiation_Patient": 250, | |
| "DrugTier": "4", | |
| "MedDed": 0, | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 19253, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 19253, | |
| "Month8_Patient": 250, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 19253, | |
| "Month6_Patient": 250, | |
| "TherapyContinuation_Patient": 2750, | |
| "TherapyInitiation_Plan": 19253, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 250, | |
| "Month6_Plan": 19253, | |
| "Month2_Patient": 250, | |
| "Month3_Plan": 19253, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 250, | |
| "CBMax": 250, | |
| "PlanName": "Anthem Platinum 90 D EPO", | |
| "Month9_Plan": 19253, | |
| "TotalPlanCost": 231036, | |
| "Month9_Patient": 250, | |
| "MetalLevel": "Platinum", | |
| "Month2_Plan": 19253, | |
| "Month8_Plan": 19253, | |
| "Month7_Patient": 250, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6025, | |
| "Month4_Plan": 19253, | |
| "Month5_Patient": 250, | |
| "Month7_Plan": 19253, | |
| "MedOOP": 3350, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 250, | |
| "Month10_Plan": 19253, | |
| "Month10_Patient": 250, | |
| "DrugId": 65 | |
| }, { | |
| "TherapyContinuation_Plan": 211783, | |
| "ProductName": "Nexavar", | |
| "RxDed": 200, | |
| "Month11_Patient": 250, | |
| "Lives": 44655, | |
| "TherapyInitiation_Patient": 450, | |
| "DrugTier": "4", | |
| "MedDed": 2500, | |
| "DedType": "Pharmacy", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 19253, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 19253, | |
| "Month8_Patient": 250, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 19253, | |
| "Month6_Patient": 250, | |
| "TherapyContinuation_Patient": 2750, | |
| "TherapyInitiation_Plan": 19053, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 250, | |
| "Month6_Plan": 19253, | |
| "Month2_Patient": 250, | |
| "Month3_Plan": 19253, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 250, | |
| "CBMax": 250, | |
| "PlanName": "Anthem Silver 70 Off Exchange EPO", | |
| "Month9_Plan": 19253, | |
| "TotalPlanCost": 230836, | |
| "Month9_Patient": 250, | |
| "MetalLevel": "Silver", | |
| "Month2_Plan": 19253, | |
| "Month8_Plan": 19253, | |
| "Month7_Patient": 250, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6026, | |
| "Month4_Plan": 19253, | |
| "Month5_Patient": 250, | |
| "Month7_Plan": 19253, | |
| "MedOOP": 7550, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 250, | |
| "Month10_Plan": 19253, | |
| "Month10_Patient": 250, | |
| "DrugId": 65 | |
| }, { | |
| "TherapyContinuation_Plan": 212733, | |
| "ProductName": "Nexavar", | |
| "Month11_Patient": 0, | |
| "Lives": 7081, | |
| "TherapyInitiation_Patient": 6100, | |
| "DrugTier": "4", | |
| "MedDed": 5600, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 19203, | |
| "PlanType": "PPO", | |
| "Month11_Plan": 19503, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 19503, | |
| "Month6_Patient": 0, | |
| "TherapyContinuation_Patient": 1800, | |
| "TherapyInitiation_Plan": 13403, | |
| "TotalTiers": "5", | |
| "Month4_Patient": 500, | |
| "Month6_Plan": 19503, | |
| "Month2_Patient": 500, | |
| "Month3_Plan": 19003, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=9xPV65t4mAk%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze PPO 40/5600/40%", | |
| "Month9_Plan": 19503, | |
| "TotalPlanCost": 226136, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 19003, | |
| "Month8_Plan": 19503, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6027, | |
| "Month4_Plan": 19003, | |
| "Month5_Patient": 300, | |
| "Month7_Plan": 19503, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G (1a/1b), PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 500, | |
| "Month10_Plan": 19503, | |
| "Month10_Patient": 0, | |
| "DrugId": 65 | |
| }]; | |
| export const SUTENT = [{ | |
| "TherapyContinuation_Plan": 185471, | |
| "ProductName": "Sutent", | |
| "RxDed": 500, | |
| "Month11_Patient": 500, | |
| "Lives": 26088, | |
| "TherapyInitiation_Patient": 1000, | |
| "DrugTier": "4", | |
| "MedDed": 6300, | |
| "DedType": "Pharmacy", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 16861, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 16861, | |
| "Month8_Patient": 500, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 16861, | |
| "Month6_Patient": 500, | |
| "TherapyContinuation_Patient": 5500, | |
| "TherapyInitiation_Plan": 16361, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 500, | |
| "Month6_Plan": 16861, | |
| "Month2_Patient": 500, | |
| "Month3_Plan": 16861, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 500, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze 60 D EPO", | |
| "Month9_Plan": 16861, | |
| "TotalPlanCost": 201832, | |
| "Month9_Patient": 500, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 16861, | |
| "Month8_Plan": 16861, | |
| "Month7_Patient": 500, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6018, | |
| "Month4_Plan": 16861, | |
| "Month5_Patient": 500, | |
| "Month7_Plan": 16861, | |
| "MedOOP": 7550, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 500, | |
| "Month10_Plan": 16861, | |
| "Month10_Patient": 500, | |
| "DrugId": 66 | |
| }, { | |
| "TherapyContinuation_Plan": 190821, | |
| "ProductName": "Sutent", | |
| "Month11_Patient": 0, | |
| "Lives": 11891, | |
| "TherapyInitiation_Patient": 6500, | |
| "DrugTier": "4", | |
| "MedDed": 6000, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 17361, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 17361, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 17361, | |
| "Month6_Patient": 0, | |
| "TherapyContinuation_Patient": 150, | |
| "TherapyInitiation_Plan": 10861, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 0, | |
| "Month6_Plan": 17361, | |
| "Month2_Patient": 150, | |
| "Month3_Plan": 17361, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze 60 D HDHP EPO", | |
| "Month9_Plan": 17361, | |
| "TotalPlanCost": 201682, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 17211, | |
| "Month8_Plan": 17361, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6019, | |
| "Month4_Plan": 17361, | |
| "Month5_Patient": 0, | |
| "Month7_Plan": 17361, | |
| "MedOOP": 6650, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 0, | |
| "Month10_Plan": 17361, | |
| "Month10_Patient": 0, | |
| "DrugId": 66 | |
| }, { | |
| "TherapyContinuation_Plan": 188821, | |
| "ProductName": "Sutent", | |
| "Month11_Patient": 0, | |
| "Lives": 782, | |
| "TherapyInitiation_Patient": 5750, | |
| "DrugTier": "4", | |
| "MedDed": 5250, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 16861, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 17361, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 17361, | |
| "Month6_Patient": 150, | |
| "TherapyContinuation_Patient": 2150, | |
| "TherapyInitiation_Plan": 11611, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 500, | |
| "Month6_Plan": 17211, | |
| "Month2_Patient": 500, | |
| "Month3_Plan": 16861, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze Pathway EPO 5250", | |
| "Month9_Plan": 17361, | |
| "TotalPlanCost": 200432, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 16861, | |
| "Month8_Plan": 17361, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6020, | |
| "Month4_Plan": 16861, | |
| "Month5_Patient": 500, | |
| "Month7_Plan": 17361, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 500, | |
| "Month10_Plan": 17361, | |
| "Month10_Patient": 0, | |
| "DrugId": 66 | |
| }, { | |
| "TherapyContinuation_Plan": 189421, | |
| "ProductName": "Sutent", | |
| "Month11_Patient": 0, | |
| "Lives": 1773, | |
| "TherapyInitiation_Patient": 6350, | |
| "DrugTier": "4", | |
| "MedDed": 5850, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 17311, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 17361, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 17361, | |
| "Month6_Patient": 0, | |
| "TherapyContinuation_Patient": 1550, | |
| "TherapyInitiation_Plan": 11011, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 500, | |
| "Month6_Plan": 17361, | |
| "Month2_Patient": 500, | |
| "Month3_Plan": 16861, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze Pathway EPO 5850", | |
| "Month9_Plan": 17361, | |
| "TotalPlanCost": 200432, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 16861, | |
| "Month8_Plan": 17361, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6021, | |
| "Month4_Plan": 16861, | |
| "Month5_Patient": 50, | |
| "Month7_Plan": 17361, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 500, | |
| "Month10_Plan": 17361, | |
| "Month10_Patient": 0, | |
| "DrugId": 66 | |
| }, { | |
| "TherapyContinuation_Plan": 190471, | |
| "ProductName": "Sutent", | |
| "Month11_Patient": 0, | |
| "Lives": 1100, | |
| "TherapyInitiation_Patient": 7400, | |
| "DrugTier": "4", | |
| "MedDed": 6900, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 17361, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 17361, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 17361, | |
| "Month6_Patient": 0, | |
| "TherapyContinuation_Patient": 500, | |
| "TherapyInitiation_Plan": 9961, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 0, | |
| "Month6_Plan": 17361, | |
| "Month2_Patient": 500, | |
| "Month3_Plan": 17361, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze Pathway EPO 6900 Online Plus", | |
| "Month9_Plan": 17361, | |
| "TotalPlanCost": 200432, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 16861, | |
| "Month8_Plan": 17361, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6022, | |
| "Month4_Plan": 17361, | |
| "Month5_Patient": 0, | |
| "Month7_Plan": 17361, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 0, | |
| "Month10_Plan": 17361, | |
| "Month10_Patient": 0, | |
| "DrugId": 66 | |
| }, { | |
| "TherapyContinuation_Plan": 188221, | |
| "ProductName": "Sutent", | |
| "Month11_Patient": 250, | |
| "Lives": 2373, | |
| "TherapyInitiation_Patient": 250, | |
| "DrugTier": "4", | |
| "MedDed": 0, | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 17111, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 17111, | |
| "Month8_Patient": 250, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 17111, | |
| "Month6_Patient": 250, | |
| "TherapyContinuation_Patient": 2750, | |
| "TherapyInitiation_Plan": 17111, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 250, | |
| "Month6_Plan": 17111, | |
| "Month2_Patient": 250, | |
| "Month3_Plan": 17111, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 250, | |
| "CBMax": 250, | |
| "PlanName": "Anthem Gold 80 D EPO", | |
| "Month9_Plan": 17111, | |
| "TotalPlanCost": 205332, | |
| "Month9_Patient": 250, | |
| "MetalLevel": "Gold", | |
| "Month2_Plan": 17111, | |
| "Month8_Plan": 17111, | |
| "Month7_Patient": 250, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6023, | |
| "Month4_Plan": 17111, | |
| "Month5_Patient": 250, | |
| "Month7_Plan": 17111, | |
| "MedOOP": 7200, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 250, | |
| "Month10_Plan": 17111, | |
| "Month10_Patient": 250, | |
| "DrugId": 66 | |
| }, { | |
| "TherapyContinuation_Plan": 190971, | |
| "ProductName": "Sutent", | |
| "Month11_Patient": 0, | |
| "Lives": 1594, | |
| "TherapyInitiation_Patient": 7900, | |
| "DrugTier": "4", | |
| "MedDed": 7900, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 17361, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 17361, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 17361, | |
| "Month6_Patient": 0, | |
| "TherapyContinuation_Patient": 0, | |
| "TherapyInitiation_Plan": 9461, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 0, | |
| "Month6_Plan": 17361, | |
| "Month2_Patient": 0, | |
| "Month3_Plan": 17361, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "PlanName": "Anthem Minimum Coverage D EPO", | |
| "Month9_Plan": 17361, | |
| "TotalPlanCost": 200432, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Catastrophic", | |
| "Month2_Plan": 17361, | |
| "Month8_Plan": 17361, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6024, | |
| "Month4_Plan": 17361, | |
| "Month5_Patient": 0, | |
| "Month7_Plan": 17361, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 0, | |
| "Month10_Plan": 17361, | |
| "Month10_Patient": 0, | |
| "DrugId": 66 | |
| }, { | |
| "TherapyContinuation_Plan": 188221, | |
| "ProductName": "Sutent", | |
| "Month11_Patient": 250, | |
| "Lives": 1040, | |
| "TherapyInitiation_Patient": 250, | |
| "DrugTier": "4", | |
| "MedDed": 0, | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 17111, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 17111, | |
| "Month8_Patient": 250, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 17111, | |
| "Month6_Patient": 250, | |
| "TherapyContinuation_Patient": 2750, | |
| "TherapyInitiation_Plan": 17111, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 250, | |
| "Month6_Plan": 17111, | |
| "Month2_Patient": 250, | |
| "Month3_Plan": 17111, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 250, | |
| "CBMax": 250, | |
| "PlanName": "Anthem Platinum 90 D EPO", | |
| "Month9_Plan": 17111, | |
| "TotalPlanCost": 205332, | |
| "Month9_Patient": 250, | |
| "MetalLevel": "Platinum", | |
| "Month2_Plan": 17111, | |
| "Month8_Plan": 17111, | |
| "Month7_Patient": 250, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6025, | |
| "Month4_Plan": 17111, | |
| "Month5_Patient": 250, | |
| "Month7_Plan": 17111, | |
| "MedOOP": 3350, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 250, | |
| "Month10_Plan": 17111, | |
| "Month10_Patient": 250, | |
| "DrugId": 66 | |
| }, { | |
| "TherapyContinuation_Plan": 188221, | |
| "ProductName": "Sutent", | |
| "RxDed": 200, | |
| "Month11_Patient": 250, | |
| "Lives": 44655, | |
| "TherapyInitiation_Patient": 450, | |
| "DrugTier": "4", | |
| "MedDed": 2500, | |
| "DedType": "Pharmacy", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 17111, | |
| "PlanType": "EPO", | |
| "Month11_Plan": 17111, | |
| "Month8_Patient": 250, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 17111, | |
| "Month6_Patient": 250, | |
| "TherapyContinuation_Patient": 2750, | |
| "TherapyInitiation_Plan": 16911, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 250, | |
| "Month6_Plan": 17111, | |
| "Month2_Patient": 250, | |
| "Month3_Plan": 17111, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 250, | |
| "CBMax": 250, | |
| "PlanName": "Anthem Silver 70 Off Exchange EPO", | |
| "Month9_Plan": 17111, | |
| "TotalPlanCost": 205132, | |
| "Month9_Patient": 250, | |
| "MetalLevel": "Silver", | |
| "Month2_Plan": 17111, | |
| "Month8_Plan": 17111, | |
| "Month7_Patient": 250, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6026, | |
| "Month4_Plan": 17111, | |
| "Month5_Patient": 250, | |
| "Month7_Plan": 17111, | |
| "MedOOP": 7550, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 250, | |
| "Month10_Plan": 17111, | |
| "Month10_Patient": 250, | |
| "DrugId": 66 | |
| }, { | |
| "TherapyContinuation_Plan": 189171, | |
| "ProductName": "Sutent", | |
| "Month11_Patient": 0, | |
| "Lives": 7081, | |
| "TherapyInitiation_Patient": 6100, | |
| "DrugTier": "4", | |
| "MedDed": 5600, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 413387, | |
| "Month5_Plan": 17061, | |
| "PlanType": "PPO", | |
| "Month11_Plan": 17361, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 17361, | |
| "Month6_Patient": 0, | |
| "TherapyContinuation_Patient": 1800, | |
| "TherapyInitiation_Plan": 11261, | |
| "TotalTiers": "5", | |
| "Month4_Patient": 500, | |
| "Month6_Plan": 17361, | |
| "Month2_Patient": 500, | |
| "Month3_Plan": 16861, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=9xPV65t4mAk%24", | |
| "Insurer": "Anthem Blue Cross of California", | |
| "Month12_Patient": 0, | |
| "CBMax": 500, | |
| "PlanName": "Anthem Bronze PPO 40/5600/40%", | |
| "Month9_Plan": 17361, | |
| "TotalPlanCost": 200432, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 16861, | |
| "Month8_Plan": 17361, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 8, | |
| "BDId": 6027, | |
| "Month4_Plan": 16861, | |
| "Month5_Patient": 300, | |
| "Month7_Plan": 17361, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G (1a/1b), PB, NPG/NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 500, | |
| "Month10_Plan": 17361, | |
| "Month10_Patient": 0, | |
| "DrugId": 66 | |
| }]; | |
| export const VOTRIENT = [{ | |
| "TherapyContinuation_Plan": 136422, | |
| "ProductName": "Votrient", | |
| "Month11_Patient": 250, | |
| "Lives": 1006, | |
| "TherapyInitiation_Patient": 250, | |
| "DrugTier": "4", | |
| "MedDed": 0, | |
| "TotalPayerLives": 40619, | |
| "Month5_Plan": 12402, | |
| "PlanType": "HMO", | |
| "Month11_Plan": 12402, | |
| "Month8_Patient": 250, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 12402, | |
| "Month6_Patient": 250, | |
| "TherapyContinuation_Patient": 2750, | |
| "TherapyInitiation_Plan": 12402, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 250, | |
| "Month6_Plan": 12402, | |
| "Month2_Patient": 250, | |
| "Month3_Plan": 12402, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=RFU9lBeJklo%24", | |
| "Insurer": "Sharp Health Plan", | |
| "Month12_Patient": 250, | |
| "CBMax": 250, | |
| "PlanName": "Sharp Platinum 90 HMO Performance", | |
| "Month9_Plan": 12402, | |
| "TotalPlanCost": 148824, | |
| "Month9_Patient": 250, | |
| "MetalLevel": "Platinum", | |
| "Month2_Plan": 12402, | |
| "Month8_Plan": 12402, | |
| "Month7_Patient": 250, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 134, | |
| "BDId": 12158, | |
| "Month4_Plan": 12402, | |
| "Month5_Patient": 250, | |
| "Month7_Plan": 12402, | |
| "MedOOP": 3350, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, NPG/PB, NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 250, | |
| "Month10_Plan": 12402, | |
| "Month10_Patient": 250, | |
| "DrugId": 68 | |
| }, { | |
| "TherapyContinuation_Plan": 136422, | |
| "ProductName": "Votrient", | |
| "Month11_Patient": 250, | |
| "Lives": 1404, | |
| "TherapyInitiation_Patient": 250, | |
| "DrugTier": "4", | |
| "MedDed": 0, | |
| "TotalPayerLives": 40619, | |
| "Month5_Plan": 12402, | |
| "PlanType": "HMO", | |
| "Month11_Plan": 12402, | |
| "Month8_Patient": 250, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 12402, | |
| "Month6_Patient": 250, | |
| "TherapyContinuation_Patient": 2750, | |
| "TherapyInitiation_Plan": 12402, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 250, | |
| "Month6_Plan": 12402, | |
| "Month2_Patient": 250, | |
| "Month3_Plan": 12402, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=RFU9lBeJklo%24", | |
| "Insurer": "Sharp Health Plan", | |
| "Month12_Patient": 250, | |
| "CBMax": 250, | |
| "PlanName": "Sharp Platinum 90 HMO Premier", | |
| "Month9_Plan": 12402, | |
| "TotalPlanCost": 148824, | |
| "Month9_Patient": 250, | |
| "MetalLevel": "Platinum", | |
| "Month2_Plan": 12402, | |
| "Month8_Plan": 12402, | |
| "Month7_Patient": 250, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 134, | |
| "BDId": 12159, | |
| "Month4_Plan": 12402, | |
| "Month5_Patient": 250, | |
| "Month7_Plan": 12402, | |
| "MedOOP": 3350, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, NPG/PB, NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 250, | |
| "Month10_Plan": 12402, | |
| "Month10_Patient": 250, | |
| "DrugId": 68 | |
| }, { | |
| "TherapyContinuation_Plan": 136422, | |
| "ProductName": "Votrient", | |
| "Month11_Patient": 250, | |
| "Lives": 2292, | |
| "TherapyInitiation_Patient": 250, | |
| "DrugTier": "4", | |
| "MedDed": 0, | |
| "TotalPayerLives": 40619, | |
| "Month5_Plan": 12402, | |
| "PlanType": "HMO", | |
| "Month11_Plan": 12402, | |
| "Month8_Patient": 250, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 12402, | |
| "Month6_Patient": 250, | |
| "TherapyContinuation_Patient": 2750, | |
| "TherapyInitiation_Plan": 12402, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 250, | |
| "Month6_Plan": 12402, | |
| "Month2_Patient": 250, | |
| "Month3_Plan": 12402, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=RFU9lBeJklo%24", | |
| "Insurer": "Sharp Health Plan", | |
| "Month12_Patient": 250, | |
| "CBMax": 250, | |
| "PlanName": "Sharp Gold 80 HMO Performance", | |
| "Month9_Plan": 12402, | |
| "TotalPlanCost": 148824, | |
| "Month9_Patient": 250, | |
| "MetalLevel": "Gold", | |
| "Month2_Plan": 12402, | |
| "Month8_Plan": 12402, | |
| "Month7_Patient": 250, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 134, | |
| "BDId": 12160, | |
| "Month4_Plan": 12402, | |
| "Month5_Patient": 250, | |
| "Month7_Plan": 12402, | |
| "MedOOP": 7200, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, NPG/PB, NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 250, | |
| "Month10_Plan": 12402, | |
| "Month10_Patient": 250, | |
| "DrugId": 68 | |
| }, { | |
| "TherapyContinuation_Plan": 136422, | |
| "ProductName": "Votrient", | |
| "Month11_Patient": 250, | |
| "Lives": 2721, | |
| "TherapyInitiation_Patient": 250, | |
| "DrugTier": "4", | |
| "MedDed": 0, | |
| "TotalPayerLives": 40619, | |
| "Month5_Plan": 12402, | |
| "PlanType": "HMO", | |
| "Month11_Plan": 12402, | |
| "Month8_Patient": 250, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 12402, | |
| "Month6_Patient": 250, | |
| "TherapyContinuation_Patient": 2750, | |
| "TherapyInitiation_Plan": 12402, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 250, | |
| "Month6_Plan": 12402, | |
| "Month2_Patient": 250, | |
| "Month3_Plan": 12402, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=RFU9lBeJklo%24", | |
| "Insurer": "Sharp Health Plan", | |
| "Month12_Patient": 250, | |
| "CBMax": 250, | |
| "PlanName": "Sharp Gold 80 HMO Premier", | |
| "Month9_Plan": 12402, | |
| "TotalPlanCost": 148824, | |
| "Month9_Patient": 250, | |
| "MetalLevel": "Gold", | |
| "Month2_Plan": 12402, | |
| "Month8_Plan": 12402, | |
| "Month7_Patient": 250, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 134, | |
| "BDId": 12161, | |
| "Month4_Plan": 12402, | |
| "Month5_Patient": 250, | |
| "Month7_Plan": 12402, | |
| "MedOOP": 7200, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, NPG/PB, NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 250, | |
| "Month10_Plan": 12402, | |
| "Month10_Patient": 250, | |
| "DrugId": 68 | |
| }, { | |
| "TherapyContinuation_Plan": 136422, | |
| "ProductName": "Votrient", | |
| "RxDed": 200, | |
| "Month11_Patient": 250, | |
| "Lives": 2807, | |
| "TherapyInitiation_Patient": 450, | |
| "DrugTier": "4", | |
| "MedDed": 2500, | |
| "DedType": "Pharmacy", | |
| "TotalPayerLives": 40619, | |
| "Month5_Plan": 12402, | |
| "PlanType": "HMO", | |
| "Month11_Plan": 12402, | |
| "Month8_Patient": 250, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 12402, | |
| "Month6_Patient": 250, | |
| "TherapyContinuation_Patient": 2750, | |
| "TherapyInitiation_Plan": 12202, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 250, | |
| "Month6_Plan": 12402, | |
| "Month2_Patient": 250, | |
| "Month3_Plan": 12402, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=RFU9lBeJklo%24", | |
| "Insurer": "Sharp Health Plan", | |
| "Month12_Patient": 250, | |
| "CBMax": 250, | |
| "PlanName": "Sharp Silver 70 Off Exchange HMO Premier", | |
| "Month9_Plan": 12402, | |
| "TotalPlanCost": 148624, | |
| "Month9_Patient": 250, | |
| "MetalLevel": "Silver", | |
| "Month2_Plan": 12402, | |
| "Month8_Plan": 12402, | |
| "Month7_Patient": 250, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 134, | |
| "BDId": 12162, | |
| "Month4_Plan": 12402, | |
| "Month5_Patient": 250, | |
| "Month7_Plan": 12402, | |
| "MedOOP": 7550, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, NPG/PB, NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 250, | |
| "Month10_Plan": 12402, | |
| "Month10_Patient": 250, | |
| "DrugId": 68 | |
| }, { | |
| "TherapyContinuation_Plan": 133672, | |
| "ProductName": "Votrient", | |
| "RxDed": 500, | |
| "Month11_Patient": 500, | |
| "Lives": 6830, | |
| "TherapyInitiation_Patient": 1000, | |
| "DrugTier": "4", | |
| "MedDed": 6300, | |
| "DedType": "Pharmacy", | |
| "TotalPayerLives": 40619, | |
| "Month5_Plan": 12152, | |
| "PlanType": "HMO", | |
| "Month11_Plan": 12152, | |
| "Month8_Patient": 500, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 12152, | |
| "Month6_Patient": 500, | |
| "TherapyContinuation_Patient": 5500, | |
| "TherapyInitiation_Plan": 11652, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 500, | |
| "Month6_Plan": 12152, | |
| "Month2_Patient": 500, | |
| "Month3_Plan": 12152, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=RFU9lBeJklo%24", | |
| "Insurer": "Sharp Health Plan", | |
| "Month12_Patient": 500, | |
| "CBMax": 500, | |
| "PlanName": "Sharp Bronze 60 HMO Performance", | |
| "Month9_Plan": 12152, | |
| "TotalPlanCost": 145324, | |
| "Month9_Patient": 500, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 12152, | |
| "Month8_Plan": 12152, | |
| "Month7_Patient": 500, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 134, | |
| "BDId": 12163, | |
| "Month4_Plan": 12152, | |
| "Month5_Patient": 500, | |
| "Month7_Plan": 12152, | |
| "MedOOP": 7550, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, NPG/PB, NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 500, | |
| "Month10_Plan": 12152, | |
| "Month10_Patient": 500, | |
| "DrugId": 68 | |
| }, { | |
| "TherapyContinuation_Plan": 139022, | |
| "ProductName": "Votrient", | |
| "Month11_Patient": 0, | |
| "Lives": 2900, | |
| "TherapyInitiation_Patient": 6500, | |
| "DrugTier": "4", | |
| "MedDed": 6000, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 40619, | |
| "Month5_Plan": 12652, | |
| "PlanType": "HMO", | |
| "Month11_Plan": 12652, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 12652, | |
| "Month6_Patient": 0, | |
| "TherapyContinuation_Patient": 150, | |
| "TherapyInitiation_Plan": 6152, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 0, | |
| "Month6_Plan": 12652, | |
| "Month2_Patient": 150, | |
| "Month3_Plan": 12652, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=RFU9lBeJklo%24", | |
| "Insurer": "Sharp Health Plan", | |
| "Month12_Patient": 0, | |
| "CBMax": 500, | |
| "PlanName": "Sharp Bronze 60 HDHP HMO Premier", | |
| "Month9_Plan": 12652, | |
| "TotalPlanCost": 145174, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Bronze", | |
| "Month2_Plan": 12502, | |
| "Month8_Plan": 12652, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 134, | |
| "BDId": 12164, | |
| "Month4_Plan": 12652, | |
| "Month5_Patient": 0, | |
| "Month7_Plan": 12652, | |
| "MedOOP": 6650, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, NPG/PB, NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 0, | |
| "Month10_Plan": 12652, | |
| "Month10_Patient": 0, | |
| "DrugId": 68 | |
| }, { | |
| "TherapyContinuation_Plan": 139172, | |
| "ProductName": "Votrient", | |
| "Month11_Patient": 0, | |
| "Lives": 212, | |
| "TherapyInitiation_Patient": 7900, | |
| "DrugTier": "4", | |
| "MedDed": 7900, | |
| "DedType": "Medical", | |
| "TotalPayerLives": 40619, | |
| "Month5_Plan": 12652, | |
| "PlanType": "HMO", | |
| "Month11_Plan": 12652, | |
| "Month8_Patient": 0, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 12652, | |
| "Month6_Patient": 0, | |
| "TherapyContinuation_Patient": 0, | |
| "TherapyInitiation_Plan": 4752, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 0, | |
| "Month6_Plan": 12652, | |
| "Month2_Patient": 0, | |
| "Month3_Plan": 12652, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=RFU9lBeJklo%24", | |
| "Insurer": "Sharp Health Plan", | |
| "Month12_Patient": 0, | |
| "PlanName": "Sharp Minimum Coverage HMO Performance", | |
| "Month9_Plan": 12652, | |
| "TotalPlanCost": 143924, | |
| "Month9_Patient": 0, | |
| "MetalLevel": "Catastrophic", | |
| "Month2_Plan": 12652, | |
| "Month8_Plan": 12652, | |
| "Month7_Patient": 0, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 134, | |
| "BDId": 12165, | |
| "Month4_Plan": 12652, | |
| "Month5_Patient": 0, | |
| "Month7_Plan": 12652, | |
| "MedOOP": 7900, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, NPG/PB, NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 0, | |
| "Month10_Plan": 12652, | |
| "Month10_Patient": 0, | |
| "DrugId": 68 | |
| }, { | |
| "TherapyContinuation_Plan": 136422, | |
| "ProductName": "Votrient", | |
| "Month11_Patient": 250, | |
| "Lives": 97, | |
| "TherapyInitiation_Patient": 250, | |
| "DrugTier": "4", | |
| "MedDed": 0, | |
| "TotalPayerLives": 40619, | |
| "Month5_Plan": 12402, | |
| "PlanType": "HMO", | |
| "Month11_Plan": 12402, | |
| "Month8_Patient": 250, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 12402, | |
| "Month6_Patient": 250, | |
| "TherapyContinuation_Patient": 2750, | |
| "TherapyInitiation_Plan": 12402, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 250, | |
| "Month6_Plan": 12402, | |
| "Month2_Patient": 250, | |
| "Month3_Plan": 12402, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=2AwzVj%2fOKhU%24", | |
| "Insurer": "Sharp Health Plan", | |
| "Month12_Patient": 250, | |
| "CBMax": 250, | |
| "PlanName": "Sharp Performance Platinum 90 HMO 0-15 + Child Dental", | |
| "Month9_Plan": 12402, | |
| "TotalPlanCost": 148824, | |
| "Month9_Patient": 250, | |
| "MetalLevel": "Platinum", | |
| "Month2_Plan": 12402, | |
| "Month8_Plan": 12402, | |
| "Month7_Patient": 250, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 134, | |
| "BDId": 12185, | |
| "Month4_Plan": 12402, | |
| "Month5_Patient": 250, | |
| "Month7_Plan": 12402, | |
| "MedOOP": 3350, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, NPG/PB, NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 250, | |
| "Month10_Plan": 12402, | |
| "Month10_Patient": 250, | |
| "DrugId": 68 | |
| }, { | |
| "TherapyContinuation_Plan": 136422, | |
| "ProductName": "Votrient", | |
| "Month11_Patient": 250, | |
| "Lives": 103, | |
| "TherapyInitiation_Patient": 250, | |
| "DrugTier": "4", | |
| "MedDed": 0, | |
| "TotalPayerLives": 40619, | |
| "Month5_Plan": 12402, | |
| "PlanType": "HMO", | |
| "Month11_Plan": 12402, | |
| "Month8_Patient": 250, | |
| "PlanYear": "Jan 1, 2019", | |
| "CoverageType": "Pharmacy", | |
| "Month12_Plan": 12402, | |
| "Month6_Patient": 250, | |
| "TherapyContinuation_Patient": 2750, | |
| "TherapyInitiation_Plan": 12402, | |
| "TotalTiers": "4", | |
| "Month4_Patient": 250, | |
| "Month6_Plan": 12402, | |
| "Month2_Patient": 250, | |
| "Month3_Plan": 12402, | |
| "State": "CA", | |
| "Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=2AwzVj%2fOKhU%24", | |
| "Insurer": "Sharp Health Plan", | |
| "Month12_Patient": 250, | |
| "CBMax": 250, | |
| "PlanName": "Sharp Premier Platinum 90 HMO 0-15 + Child Dental", | |
| "Month9_Plan": 12402, | |
| "TotalPlanCost": 148824, | |
| "Month9_Patient": 250, | |
| "MetalLevel": "Platinum", | |
| "Month2_Plan": 12402, | |
| "Month8_Plan": 12402, | |
| "Month7_Patient": 250, | |
| "Notes": "Projected member months. Reported in member months so divided by 12", | |
| "ParentId": 134, | |
| "BDId": 12186, | |
| "Month4_Plan": 12402, | |
| "Month5_Patient": 250, | |
| "Month7_Plan": 12402, | |
| "MedOOP": 3350, | |
| "TA": "Renal Cell Carcinoma", | |
| "TierDescrip": "G, NPG/PB, NPB, S", | |
| "FileType": "URRT", | |
| "Month3_Patient": 250, | |
| "Month10_Plan": 12402, | |
| "Month10_Patient": 250, | |
| "DrugId": 68 | |
| }]; |
Sign up for free
to join this conversation on GitHub.
Already have an account?
Sign in to comment